Liver engrafting cells, assays, and uses thereof
View Patent ↗A substantially enriched mammalian hepatic liver engrafting cell population is provided. Methods are provided for the isolation and culture of this liver engrafting cell, for example, a cell population containing human liver engrafting cells wherein at least one cell in the population is HLA low/neg ; and expresses at least one marker selected from the group consisting of albumin; 5E12; Ep-Cam; CD49f; and E-Cadherin. The progenitor cells are obtained from a variety of sources, including fetal and adult tissues. The cells are useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products, including mRNA species useful in identifying genes specifically expressed in these cells, and as targets for the discovery of factors or molecules that can affect them.
1. A cell population comprising human liver engrafting cells wherein at least 50% of the cells in the population are human liver engrafting cells that are each HLA low/neg ; 5E12 + ; and express albumin, and wherein said HLA low/neg ; 5E12 + ; and albumin expressing cells in said population give rise to mature hepatocytes.
2. The cell population of claim 1 , wherein the at least 50% of the cells in said population are also negative for CD117 and CD14.
3. The cell population of any one of claim 1 or 2 , wherein said human liver engrafting cells are genetically modified to comprise an exogenous DNA vector.